Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 2001, p. 3920-3926, Vol. 39, No. 11
Research Animal Diagnostic and Investigative Laboratory,
Department of Veterinary Pathobiology, University of Missouri,
Columbia, Missouri 652111; Animal Health
Diagnostic Laboratory, Laboratory Animal Sciences Program, NCI-FCRDC,
Science Applications International Corporation, Frederick,
Maryland 217012; Forsyth Institute,
Boston, Boston, Massachusetts 021153;
Veterinary and Tumor Pathology Section, Center for Cancer
Research, National Cancer Institute, Frederick, Maryland
021154; and Division of Comparative
Medicine, Massachusetts Institute of Technology, Cambridge,
Massachusetts 021395
Received 3 July 2001/Returned for modification 7 August
2001/Accepted 28 August 2001
Over the past decade, several Helicobacter species have
been isolated from rodents. With the advent of PCR for the diagnosis of
infectious agents, it has become clear that several previously uncharacterized Helicobacter species also colonize rodents.
In this report, we describe a novel urease-negative helicobacter, Helicobacter typhlonius sp. nov., which was isolated from
colonies of laboratory mice independently by two laboratories.
Infection of immunodeficient mice by this bacterium resulted in
typhlocolitis similar to that observed with other helicobacter
infections. H. typhlonius is genetically most closely
related to H. hepaticus. Like H. hepaticus, it
is a spiral bacterium with bipolar sheathed flagella. However, this
novel species contains a large intervening sequence in its 16S rRNA
gene and is biochemically distinct from H. hepaticus.
Notably, H. typhlonius does not produce urease or H2S nor does it hydrolize indoxyl-acetate. Compared to
other Helicobacter species that commonly colonize rodents,
H. typhlonius was found to be less prevalent than H. hepaticus and H. rodentium but as prevalent as
H. bilis. H. typhlonius joins a growing list of
helicobacters that colonize mice and are capable of inducing enteric
disease in various strains of immunodeficient mice.
The genus Helicobacter
has rapidly expanded since the discovery of the type species,
Helicobacter pylori, in 1982. This genus currently contains
24 named species and numerous provisionally named species. It is likely
that several novel Helicobacter species await discovery.
Members of this genus are microaerobic, have a fusiform or curved to
spiral rod morphology and are motile by flagella that vary in number
and location among different species (44). All known
helicobacters live in human and animal hosts, where colonization occurs
primarily in the gastrointestinal tract. The type species, H. pylori, was isolated from the stomach of humans and has been
associated with a variety of gastric anomalies including gastritis,
peptic ulcer disease, gastric carcinoma, and gastric mucosa-associated
lymphoma (25, 26, 28, 29, 48). Like H. pylori,
other species of Helicobacter have also been shown to
colonize the stomach and cause disease in animals. Gastric colonizers
include H. felis, H. mustelae, H. acinonychis, H. bizzozeronii, H. heilmannii, H. salomonis, and a recently isolated novel
Helicobacter sp. of dolphins (5, 19-21, 30).
Several species of Helicobacter have been identified in
rodents, including the species H. hepaticus, H. bilis, H. muridarum, H. aurati, H. cinaedi, H. cholecystus, H. trogontum,
H. rodentium, and a bacterium morphologically resembling
Helicobacter Flexispira taxon 8 (formerly Flexispira
rappini) (9, 13, 14, 17, 24, 27, 31, 32, 36, 37). Of
these, only H. muridarum and H. aurati have been
demonstrated to colonize the rodent stomach. Instead, most rodent
helicobacters colonize the large intestine and in some cases
translocate to the liver and colonize the biliary system.
Several rodent Helicobacter spp., including H. hepaticus, H. bilis, and H. rodentium, have
been associated with enterohepatic disease. H. hepaticus has
been shown to cause inflammatory bowel disease and chronic active
hepatitis in both immunocompetent and immunodeficient mice (2,
12, 45-47). Conversely, H. bilis and H. rodentium have only been convincingly associated with disease in
immunodeficient rodents (15, 18, 38). Lesions caused by
these rodent Helicobacter spp. often mimic those seen in
human idiopathic enterohepatic diseases, especially inflammatory bowel diseases. Therefore, rodent helicobacter infections have attracted the
attention of scientists interested in the study of these diseases. Not
only have these infections been used as models for disease, but
inadvertent infections by rodent Helicobacter spp. have
confounded interpretation of results from established models of
inflammatory bowel disease (2, 7, 10, 23). As a result, it
has become increasingly important to ascertain the
Helicobacter status of experimental animals prior to the
initiation of studies using rodent inflammatory bowel disease models.
With the advent of molecular diagnostic techniques such as PCR designed
to detect known Helicobacter species, it is becoming increasingly evident that rodents are colonized by numerous novel Helicobacter species. Our laboratories have been screening
rodents by PCR and culture for several years. As a result, several
uncharacterized Helicobacter spp. have been identified
(L. K. Riley, unpublished results; J. G. Fox, unpublished
results). Whether or not these novel species of Helicobacter
cause disease awaits further systematic study of infected animals.
Recently, Fox et al. described a novel urease-negative helicobacter,
designated Helicobacter sp. strain MIT 97-6810, that was
isolated from interleukin-10 (IL-10)-deficient mice with typhlocolitis (10). IL-10-deficient and SCID/NCr mice experimentally
infected with this Helicobacter strain also developed
typhlitis, colitis, and proctitis, and experimentally infected A/JCr
mice developed minimal to mild typhlitis. Shortly thereafter, Franklin
et al. described a disease syndrome characterized by proliferative
typhlocolitis in C.B-17 scid/scid mice naturally and
experimentally infected with a novel species of
Helicobacter that was provisionally named "Helicobacter typhlonicus" (16). H. typhlonicus was genetically and morphologically identical to
Helicobacter sp. strain MIT 97-6810. In this report, we
propose to use the more appropriate neo-Latin adjective
"typhlonius" and formally name this novel helicobacter Helicobacter typhlonius. Furthermore, we demonstrate
that H. typhlonius is a common intestinal colonizer of
research mice.
Bacterial isolates.
Isolates MIT 97-6810 and MIT 97-6811 were isolated from IL-10 DNA sequencing.
Sequence analyses of bacterial 16S rRNA
genes were performed as previously described (13, 14).
Briefly, bacterial DNA was extracted from samples, and sequencing
templates were prepared by PCR with one of the following primer sets:
(i) C70f and B37r, (ii) H35f and H587r, (iii) C70f and H676r, (iv)
H276f and cg4r, and (v) H276f and p13Br (3, 13, 33, 34).
Templates were purified on 3.5% polyacrylamide gels, and the gene
sequence was determined by using either the Taq Dye Deoxy
Termantory Cycle Sequencing Kit (Applied BioSystems, Inc., Foster City,
Calif) or the TAQuence Cycle Seq Kit (U.S. Biochemicals, Cleveland,
Ohio) (10, 16). Sequence analyses were performed by using
the Sequence Analysis Software Package (Wisconsin Package, version
10.0; Genetics Computer Group, Inc., Madison, Wis.). The sequences
(1,307 bp) of the five novel Helicobacter isolates were
aligned with sequences of 32 bacteria representing formally and
provisionally named species of Helicobacter, and select
species of Wolinella, Campylobacter, and Arcobacter. A matrix of pairwise evolutionary distances
between aligned sequences (similarity matrix) was constructed; both
uncorrected distances and corrected distances made using the
Jukes-Cantor method (22) were calculated. A phylogenetic
tree was created by the neighbor-joining method (35, 42,
43). Sequence data used for comparisons were obtained from
GenBank (accession numbers are provided in Fig.
1).
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.11.3920-3926.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Helicobacter typhlonius sp. nov., a
Novel Murine Urease-Negative Helicobacter
Species
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/
knockout mice on a
C57BL6/129-Ola background (10). One mouse had a rectal
prolapse, while the second was clinically normal. Isolates MU 96-1 and
MU 96-2 were cultured from feces of BALB/c mice (16).
There was no history of clinical signs, abnormal necropsy findings, or
significant histologic lesions in mice from this colony. Isolate MU
96-3 was recovered from the feces of a FOX CHASE SCID
C.B-17/IcrCrl-scidBR (SCID) mouse that had been inoculated
with MU 96-1 (16). Isolation procedures were similar to
those previously described for the isolation of H. hepaticus and H. bilis (9, 13, 14). Briefly, fecal
material was homogenized in either phosphate-buffered saline (PBS) or
brain heart infusion broth containing horse serum and yeast extract.
The fecal slurries were filtered through either a 0.45- or 0.80-µm
(pore-size) filter and placed on plates of Trypticase soy or brucella
agar that contained 5% sheep blood. In some cases, blood agar plates
also contained trimethoprim, vancomycin, and polymyxin. Cultures were
incubated in a microaerobic environment at 37 and 42°C for up to 2 weeks.

View larger version (55K):
[in a new window]
FIG. 1.
Phylogenetic tree of members of the genera
Helicobacter, Campylobacter, "Flexispira," Wolinella,
and Arcobacter based on 16S ribosomal DNA sequences and
prepared by using the neighbor-joining method. Phylogenetic distances
between bacteria are calculated by totaling horizontal branches between
bacteria. Bar, 1 nucleotide substitution per 100 nucleotides.
Specific identification of H. typhlonius by PCR.
Two PCR primer sets were generated from sequence data. Primer set 1 consisted of the forward primer JGF-F1 (5'-GAA ACT ATC ACT CTA GAG
TAT G-3') and the reverse primer JGF-R1 (5'-TGC TCC TCA TTG
TAT GCC-3'). This primer set amplified a 622-bp fragment from
nucleotide positions 639 to 1260 (Escherichia coli
numbering). The following conditions were used: 50 µl of reaction
mixture with 50 ng of template, 200 µg of bovine serum albumin
ml
1, 5 pmol of primer, 1× reaction buffer (100 mM
Tris-HCl, 15 mM MgCl2, 500 mM KCl; pH 8.3; Roche Molecular
Biochemicals, Indianapolis, Ind.), and 2.5 U of Taq, with 40 cycles of 1-min denaturation at 94°C, 1-min annealing at 52°C, and
1-min extension at 72°C. Primer set 2 consisted of the forward primer
Ht184f (5'-TTA AAG ATA TTC TAG GGG TAT AT-3') and the
reverse primer Ht640r (5'-TCT CCC ATA CTC TAG AGT GA-3').
The forward primer was designed from the intervening sequence.
This primer set amplified a 455-bp fragment from base position 131 of
the intervening sequence to nucleotide position 665 (E. coli
numbering). The following conditions were used for this PCR: 50 µl of
reaction mixture with 1.25 µg of template, 2.5 pmol of primer, 10×
reaction buffer, and 1.25 U of Taq, with 45 cycles of 2-s
denaturation at 94°C, 10-s annealing at 53°C, and 30-s extension at
72°C. Samples were analyzed by PCR as previously described (1,
10, 34).
Biochemical characterization. To further characterize isolates, phenotypic tests commonly used to characterize helicobacters were performed (14). Growth was examined at 25, 37, and 42°C. Tolerances to 1% (wt/vol) glycine and 1.5% NaCl were determined as previously described (9). Bacteria were tested for urease activity by a selective rapid urea test (Remel, Lenexa, Kans.) and examined for oxidase and catalase activity by standard microbiological methods (6). Alkaline phosphatase activity and hydrolysis of indoxyl-acetate were analyzed by using the Ani-Ident system (bioMerieux Vitek, Inc., Hazelwood, Mo.). Gamma-glutamyltransferase and alkaline phosphatase activities, hydrolysis of hippurate, reduction of nitrate to nitrite, and production of hydrogen sulfide were analyzed by using the Campy identification system (bioMerieux Vitek). Reduction of nitrate was also determined by using nitrate impregnated disks (Remel). Susceptibilities to cephalothin and nalidixic acid were determined by culturing isolates in the presence of antibiotic impregnated disks (Remel).
Electron microscopy. Bacteria were collected from blood agar plates, placed in PBS (pH 7.4), and centrifuged at 12,000 × g. Bacteria were washed, resuspended, stained with phosphotungstic acid for 20 to 30 s, and examined with either a JEOL model JEM-1 200EX or an Hitachi H-6700 transmission electron microscope.
Nucleotide sequence accession numbers.
The type
strains of H. typhlonius sp. nov., MIT 97-6810 and MU 96-1, isolated from the intestinal contents of an IL-10
/
knockout mouse and a BALB/c mouse, respectively, have been deposited with The American Type Culture Collection (ATCC) and are designated strains ATCC BAA-367T and ATCC BAA-368. The 16S rRNA
sequences of the type strains are available for electronic retrieval
from GenBank under accession numbers AF127912 and AF061104.
| |
RESULTS |
|---|
|
|
|---|
Bacterial analyses. Five isolates of the H. typhlonius (MIT 97-6810, MIT 97-6811, MU 96-1, MU 96-2, and MU 96-3), were examined by 16S rRNA gene sequence analysis. Sequences were obtained from a 1,614-bp fragment or a 1,448-bp fragment internal to the 1,614-bp fragment. The 1,448-bp fragments from all five isolates were 100% identical. A 166-bp intervening sequence (IVS) was identified following position 198 in all isolates. This IVS occupied the area normally occupied by a seven-base stem-loop centered on position 210 in several other species of Helicobacter. Because not all helicobacters contain an IVS, this sequence was removed for genetic comparisons. The consensus sequence from the novel Helicobacter sp. was aligned with sequences from bacteria of the genera Helicobacter, Campylobacter, and Wolinella as previously described (13, 14). A similarity matrix was generated (data not shown), and a phylogenetic tree was constructed (Fig. 1). Sequences of all known rodent helicobacters were included in this comparison. On the basis of this comparison, H. typhlonius was most closely related to H. hepaticus but was a distinct species exhibiting 97.64% similarity and containing the aforementioned intervening sequence.
Six additional isolates obtained from mice inoculated with MIT 97-6810 were analyzed by PCR with primer set 1. Isolates 98-6781 and 98-6782 were from 4-week postinoculation mice, and isolates 98-784, 98-6785, 98-7686, and 98-6787 were from 18-week postinoculation mice. All isolates were found to be positive by this PCR. DNA from H. rodentium, another urease-negative Helicobacter sp., did not amplify with this primer set. Phenotypic tests commonly used to characterize helicobacters were performed on MU 96-1, MU 96-2, MIT 97-6810, and MIT 97-6811. All isolates had identical biochemical phenotypes (Table 1). Cells were motile and helical and grew on moist blood agar as transparent pinpoint colonies. Upon ultrastructural examination, isolates MIT 97-6810 and MU 96-1 were identical. The majority of bacteria were 0.3-µm by 2- to 3-µm curved to spiral rods, with single sheathed bipolar flagella and no periplasmic fibers (Fig. 2).
|
|
H. typhlonius is common in research mice. Fecal samples submitted to the University of Missouri Research Animal Diagnostic and Investigative Laboratory for helicobacter testing were examined by PCR with primer sets designed to detect (i) all species of Helicobacter (generic test), (ii) H. hepaticus, (iii) H. bilis, (iv) H. rodentium, and (v) H. typhlonius (with primer set 2 [Ht184f and Ht640r]). Samples that were found to be positive by the generic helicobacter PCR but negative by all species tests were designated as positive for Helicobacter spp. Of 1,271 samples tested from November 1999 through April 2000, 4.88% were positive for H. typhlonius, 16.44% were positive for H. hepaticus, 4.33% were positive for H. bilis, 15.11% were positive for H. rodentium, and 10.54% were positive for Helicobacter spp.
| |
DISCUSSION |
|---|
|
|
|---|
In this report we describe the phylogenetic characterization of a
novel urease-negative spiral bacterium that was isolated independently
by two laboratories. This bacterium merits a formal name as a novel
Helicobacter species because it is genetically distinct from
other Helicobacter spp. and exhibits important biochemical differences compared to its closest relatives. We propose the name
H. typhlonius because this bacteria was isolated from
inflamed intestinal contents of naturally infected
IL-10
/
mice and has, under defined conditions, produced
inflammation of the ceca and colon of both IL-10
/
and
SCID mice (10, 16).
H. typhlonius is most closely related to H. hepaticus (97.44%), and it clusters with H. muridarum and H. trogontum. While H. typhlonius is on a genetic basis closely related to these species, it also possesses a unique IVS in its 16S rRNA sequence, and it is morphologically and/or biochemically distinguishable from its closest phylogenetic relatives. Unlike H. muridarum and H. trogontum, H. typhlonius lacks the periplasmic fibers and multiple flagella and does not have gamma-glutamyltransferase activity. H. typhlonius is morphologically similar to H. hepaticus; however, unlike H. hepaticus, it does not produce H2S or hydrolyze indoxyl-acetate. Perhaps the most dramatic difference between H. typhlonius and its three closest relatives is its lack of urease activity. Preliminary data obtained by both of our laboratories suggest that H. typhlonius lacks the gene for urease (10; C. S. Beckwith, unpublished results).
The role of urease in species of Helicobacter that colonize the large intestine is unknown. Both urease-positive (H. hepaticus and H. bilis) and two urease-negative helicobacters have been shown to cause proliferative disease of the cecum and colon (10, 15, 16, 39, 46). Because the novel urease-negative helicobacter described by Shomer et al. produces significant hepatic and intestinal disease in A/JCr mice, as well as in immunodeficient mice, it is unlikely that urease plays a major role in the pathogenesis of enteric disease (40). Interestingly, only mild portal inflammation in the liver has been seen in H. typhlonius-infected immunocompromised mice (10, 16). This is in contrast to the severe necrotizing liver disease seen in SCID mice infected with either H. hepaticus and H. bilis. There was no evidence of colonization of the liver by H. typhlonius, as evidenced by uniformly negative PCR results (16). Also, H. rodentium, another urease-negative helicobacter, has not been isolated from livers nor is it associated with liver disease (37). This may be due to a lack of undetermined virulence factors in both of these urease-negative Helicobacter spp.
Several other species of Helicobacter also lack urease activity. These include H. pullorum, H. canis, H. fennelliae, H. cinaedi, and H. canadensis (8, 11, 41, 44). Interestingly, all of have been isolated from the feces of diarrheic humans, supporting the premise that urease is not critical to the pathogenesis of enteric disease. Also, H. pullorum, H. cinaedi, and H. canis have been isolated from inflamed livers (11, 41). The only other known rodent helicobacters that lack urease are an unnamed novel species of Helicobacter that can cause cholangiohepatitis and inflammatory bowel disease (40) and H. rodentium (37). Coinfection with H. rodentium and H. bilis has been associated with diarrhea in SCID mice, suggesting that, like H. typhlonius, H. rodentium may be pathogenic to immunocompromised mice (38). Although H. typhlonius is genetically distinct from H. rodentium (94.28% identity), these bacteria are biochemically and phenotypically very similar. Both agents produce catalase, reduce nitrate, and have bipolar flagella, and both are negative for indoxyl-acetate hydrolysis and gamma-glutamyltranspeptidase and alkaline phosphatase activities. Like H. rodentium, H. typhlonius grows in the presence of 1% glycine, but the majority of the bacteria grown in these conditions are degenerative coccoid forms. The only other known phenotypic differences are growth in anaerobic conditions, susceptibility to nalidixic acid, and flagellar morphology; H. rodentium grows in anaerobic conditions, is resistant to nalidixic acid, and has nonsheathed flagella, whereas H. typhlonius does not grow in anaerobic conditions, is susceptible to nalidixic acid, and has sheathed flagella. Another previously described, unnamed novel urease-negative Helicobacter sp. is also characterized by single polar sheathed flagella (40).
Screening of over 1,000 fecal samples submitted to the University of Missouri Research Animal Diagnostic and Investigative Laboratory demonstrated H. typhlonius colonization in 4.88% of the samples. This finding suggests that H. typhlonius is prevalent in laboratory rodent colonies in the United States. H. typhlonius was not as prevalent as H. hepaticus (16.44%) or H. rodentium (15.11%) but was slightly more prevalent than H. bilis (4.33%). While these data must be interpreted cautiously because some samples were likely submitted from colonies known or suspected to be contaminated by Helicobacter spp., they highlight that multiple Helicobacter spp. are common in research mouse colonies. Furthermore, the IL-10 knockout mice from which the MIT isolates were obtained originated in Germany, suggesting that H. typhlonius has a worldwide distribution (10).
In conclusion, geographically disparate laboratories independently identified a novel Helicobacter sp. that is capable of causing enteric disease in immunodeficient mice (10, 16). We propose to name this species H. typhlonius. Routine screening of rodent colonies throughout the United States suggests that H. typhlonius is prevalent in rodent colonies. Its importance in causing naturally occurring gastrointestinal disease in immunocompetent mice, as well as enteric disease in other hosts, will require further studies.
Description of H. typhlonius sp. nov. Helicobacter typhlonius (ti.flo' ni.us Gr. n. typhlon, cecum; N.L. adj. typhlonius, pertaining to the cecum). Filamentous cells are 0.3- by 2- to 3-µm curved to spiral rods, with no periplasmic fibers. Cells do not form spores and are motile by single sheathed bipolar flagella. Colonies are pinpoint. Cells grow in microaerobic but not in anaerobic or aerobic conditions. There is growth at 37 or 42°C but not at 25°C nor in the presence of 1.5% NaCl. There is growth in the presence of 1% glycine; however, the majority of cells harvested in these conditions have coccoid morphology. H. typhlonius is oxidase and catalase positive but does not have urease, alkaline phosphatase, or gamma-glutamyltransferase activities. Nitrate is reduced to nitrite. Indoxyl-acetate and hippurate are not hydrolyzed. Cells are resistant to cephalothin and sensitive to nalidixic acid.
| |
ACKNOWLEDGMENTS |
|---|
We thank H. G. Trüper of the Institut for Mikrobiology and Biotechnology in Bonn, Germany, for assistance with bacterial nomenclature and Beth Livingston, Samantha McCasland, Sue Bingaman, Sandy Xu, and Allen Maddy for excellent technical support.
This research was supported in part by a grant from the Pittsburgh Supercomputing Center through the NIH National Center for Research Resources resource grants P41RR0600 (C.L.F.) and R01CA067529 (J.G.F.).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Comparative Medicine, Massachusetts Institute of Technology, Bldg. 16-825C, 77 Massachusetts Ave., Cambridge, MA 02139-4307. Phone: (617) 253-1757. Fax: (617) 258-5708. E-mail: jgfox{at}mit.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Beckwith, C. S., C. L. Franklin, R. R. Hook, Jr., C. L. Besch-Williford, and L. K. Riley. 1997. Fecal PCR assay for diagnosis of Helicobacter infection in laboratory rodents. J. Clin. Microbiol. 35:1620-1623[Abstract]. |
| 2. | Cahill, R. J., C. J. Foltz, J. G. Fox, C. A. Dangler, F. Powrie, and D. B. Schauer. 1997. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect. Immun. 65:3126-3131[Abstract]. |
| 3. | Cox, R. A., K. Kempsell, L. Fairclough, and M. J. Colston. 1991. The 16S ribosomal RNA of Mycobacterium leprae contains a unique sequence which can be used for identification by the polymerase chain reaction. J. Med. Microbiol. 35:284-290[Abstract]. |
| 4. | Dewhirst, F. E., J. G. Fox, and S. L. On. 2000. Recommended minimal standards for describing new species of the genus Helicobacter. Int. J. Syst. Evol. Microbiol. 50(Pt. 6):2231-2237. |
| 5. |
Eaton, K. A.,
F. E. Dewhirst,
M. J. Radin,
J. G. Fox,
B. J. Paster,
S. Krakowka, and D. R. Morgan.
1993.
Helicobacter acinonyx sp. nov., isolated from cheetahs with gastritis.
Int. J. Syst. Bacteriol.
43:99-106 |
| 6. | Finegold, S. M., and W. J. Martin. 1982. Diagnostic microbiology, 6th ed. C. V. Mosby Co., St. Louis, Mo. |
| 7. | Foltz, C. J., J. G. Fox, R. C. Cahill, J. C. Murphy, L. Yan, B. Shames, and D. B. Schauer. 1998. Spontaneous inflammatory bowel diseae in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 3:69-78[CrossRef][Medline]. |
| 8. |
Fox, J. G.,
C. C. Chien,
F. E. Dewhirst,
B. J. Paster,
Z. Shen,
P. L. Melito,
D. L. Woodward, and F. G. Rodgers.
2000.
Helicobacter canadensis sp. nov. isolated from humans with diarrhea: an example of an emerging pathogen.
J. Clin. Microbiol.
38:2546-2549 |
| 9. |
Fox, J. G.,
F. E. Dewhirst,
J. G. Tully,
B. J. Paster,
L. Yan,
N. S. Taylor,
M. J. Collins, Jr.,
P. L. Gorelick, and J. M. Ward.
1994.
Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.
J. Clin. Microbiol.
32:1238-1245 |
| 10. |
Fox, J. G.,
P. L. Gorelick,
M. C. Kullberg,
Z. Ge,
F. E. Dewhirst, and J. M. Ward.
1999.
A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice.
Infect. Immun.
67:1757-1762 |
| 11. |
Fox, J. G.,
L. Handt,
B. J. Sheppard,
S. Xu,
F. E. Dewhirst,
S. Motzel, and H. Klein.
2001.
Isolation of Helicobacter cinaedi from the colon, liver and mesenteric lymph node of a rhesus monkey with chronic colitis and hepatitis.
J. Clin. Microbiol.
39:1580-1585 |
| 12. | Fox, J. G., L. Yan, B. Shames, J. Campbell, J. C. Murphy, and X. Li. 1996. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect. Immun. 64:3673-3681[Abstract]. |
| 13. | Fox, J. G., L. L. Yan, F. E. Dewhirst, B. J. Paster, B. Shames, J. C. Murphy, A. Hayward, J. C. Belcher, and E. N. Mendes. 1995. Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J. Clin. Microbiol. 33:445-454[Abstract]. |
| 14. | Franklin, C. L., C. S. Beckwith, R. S. Livingston, L. K. Riley, S. V. Gibson, C. L. Besch-Williford, and R. R. Hook, Jr. 1996. Isolation of a novel Helicobacter species, Helicobacter cholecystus sp. nov., from the gallbladders of Syrian hamsters with cholangiofibrosis and centrilobular pancreatitis. J. Clin. Microbiol. 34:2952-2958[Abstract]. |
| 15. | Franklin, C. L., L. K. Riley, R. S. Livingston, C. S. Beckwith, C. L. Besch-Williford, and J. R. R. Hook. 1998. Enterohepatic lesions in SCID mice infected with Helicobacter bilis. Lab. Anim. Sci. 48:334-339[Medline]. |
| 16. | Franklin, C. L., L. K. Riley, R. S. Livingston, C. S. Beckwith, R. R. Hook, Jr., C. L. Besch-Williford, R. Hunziker, and P. L. Gorelick. 1999. Enteric lesions in SCID mice infected with "Helicobacter typhlonicus," a novel urease-negative Helicobacter species. Lab. Anim. Sci. 49:496-505[Medline]. |
| 17. |
Gebhart, C. J.,
C. L. Fennell,
M. P. Murtaugh, and W. E. Stamm.
1989.
Campylobacter cinaedi is normal intestinal flora in hamsters.
J. Clin. Microbiol.
27:1692-1694 |
| 18. | Haines, D. C., P. L. Gorelick, J. K. Battles, K. M. Pike, R. J. Anderson, J. G. Fox, N. S. Taylor, Z. Shen, F. E. Dewhirst, M. R. Anver, and J. M. Ward. 1998. Inflammatory large bowel disease in immunodeficient rats naturally and experimentally infected with Helicobacter bilis. Vet. Pathol. 35:202-208[Abstract]. |
| 19. |
Hanninen, M. L.,
I. Happonen,
S. Saari, and K. Jalava.
1996.
Culture and characteristics of Helicobacter bizzozeronii, a new canine gastric Helicobacter sp.
Int. J. Syst. Bacteriol.
46:160-166 |
| 20. |
Harper, C. M.,
C. A. Dangler,
S. Xu,
Y. Feng,
Z. Shen,
B. Sheppard,
A. Stamper,
F. E. Dewhirst,
B. J. Paster, and J. G. Fox.
2000.
Isolation and characterization of a Helicobacter sp. from the gastric mucosa of dolphins, Lagenorhynchus acutus and Delphinus delphis.
Appl. Environ. Microbiol.
66:4751-4757 |
| 21. |
Jalava, K.,
M. Kaartinen,
M. Utriainen,
I. Happonen, and M. L. Hanninen.
1997.
Helicobacter salomonis sp. nov., a canine gastric Helicobacter sp. related to Helicobacter felis and Helicobacter bizzozeronii.
Int. J. Syst. Bacteriol.
47:975-982 |
| 22. | Jukes, T. H., and C. R. Cantor. 1969. Evolution of protein molecules, p. 21-132. In H. N. Munro (ed.), Mammalian protein metabolism, vol. 3. Academic Press, New York, N.Y. |
| 23. |
Kullberg, M. C.,
J. M. Ward,
P. L. Gorelick,
P. Caspar,
S. Hieny,
A. Cheever,
D. Jankovic, and A. Sher.
1998.
Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism.
Infect. Immun.
66:5157-5166 |
| 24. |
Lee, A.,
M. W. Phillips,
O. J. L.,
B. J. Paster,
F. E. Dewhirst,
G. J. Fraser,
J. G. Fox,
L. I. Sly,
P. J. Romaniuk,
T. J. Trust, et al.
1992.
Helicobacter muridarum sp. nov., a microaerophilic helical bacterium with a novel ultrastructure isolated from the intestinal mucosa of rodents.
Int. J. Syst. Bacteriol.
42:27-36 |
| 25. | Marshall, B. J. 1990. Campylobacter pylori: its link to gastritis and peptic ulcer disease. Rev. Infect. Dis. 12:S87-S93. |
| 26. | Marshall, B. J., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i:1311-1315. |
| 27. |
Mendes, E. N.,
D. M. Queiroz,
F. E. Dewhirst,
B. J. Paster,
S. B. Moura, and J. G. Fox.
1996.
Helicobacter trogontum sp. nov., isolated from the rat intestine.
Int. J. Syst. Bacteriol.
46:916-921 |
| 28. | Parsonnet, J. 1995. Bacterial infection as a cause of cancer. Environ. Health Perspect. 103(Suppl. 8):263-268. |
| 29. | Parsonnet, J. 1998. Helicobacter pylori. Infect. Dis. Clin. N. Am. 12:185-197[CrossRef][Medline]. |
| 30. |
Paster, B. J.,
A. Lee,
J. G. Fox,
F. E. Dewhirst,
L. A. Tordoff,
G. J. Fraser,
J. L. O'Rourke,
N. S. Taylor, and R. Ferrero.
1991.
Phylogeny of Helicobacter felis sp. nov., Helicobacter mustelae, and related bacteria.
Int. J. Syst. Bacteriol.
41:31-38 |
| 31. |
Patterson, M. M.,
M. D. Schrenzel,
Y. Feng, and J. G. Fox.
2000.
Gastritis and intestinal metaplasia in Syrian hamsters infected with Helicobacter aurati and two other microaerobes.
Vet. Pathol.
37:589-596 |
| 32. |
Patterson, M. M.,
M. D. Schrenzel,
Y. Feng,
S. Xu,
F. E. Dewhirst,
B. J. Paster,
S. A. Thibodeau,
J. Versalovic, and J. G. Fox.
2000.
Helicobacter aurati sp. nov., a urease-positive Helicobacter species cultured from gastrointestinal tissues of Syrian hamsters.
J. Clin. Microbiol.
38:3722-3728 |
| 33. | Relman, D. A., J. S. Loutit, T. M. Schmidt, S. Falkow, and L. S. Tompkins. 1990. The agent of bacillary angiomatosis: an approach to the identification of uncultured pathogens. N. Engl. J. Med. 323:1573-1580[Abstract]. |
| 34. | Riley, L. K., C. L. Franklin, R. R. Hook, Jr., and C. Besch-Williford. 1996. Identification of murine helicobacters by PCR and restriction enzyme analyses. J. Clin. Microbiol. 34:942-946[Abstract]. |
| 35. | Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425[Abstract]. |
| 36. |
Schauer, D. B.,
N. Ghori, and S. Falkow.
1993.
Isolation and characterization of "Flexispira rappini" from laboratory mice.
J. Clin. Microbiol.
31:2709-2714 |
| 37. |
Shen, Z.,
J. G. Fox,
F. E. Dewhirst,
B. J. Paster,
C. J. Foltz,
L. Yan,
B. Shames, and L. Perry.
1997.
Helicobacter rodentium sp. nov., a urease-negative Helicobacter species isolated from laboratory mice.
Int. J. Syst. Bacteriol.
47:627-634 |
| 38. | Shomer, N. H., C. A. Dangler, R. P. Marini, and J. G. Fox. 1998. Helicobacter bilis/Helicobacter rodentium co-infection associated with diarrhea in a colony of scid mice. Lab. Anim. Sci. 48:455-459[Medline]. |
| 39. | Shomer, N. H., C. A. Dangler, M. D. Schrenzel, and J. G. Fox. 1997. Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora. Infect. Immun. 65:4858-4864[Abstract]. |
| 40. |
Shomer, N. H.,
C. A. Dangler,
M. D. Schrenzel,
M. T. Whary,
B. J. Paster,
F. E. Dewhirst, and J. G. Fox.
2001.
Cholangiohepatitis and inflammatory bowel disease (IBD) induced by a novel urease-negative Helicobacter species in A/J and Tac:ICR:Hascid mice.
Biol. Exp. Med.
226:420-428 |
| 41. |
Stanley, J.,
D. Linton,
A. P. Burens,
F. E. Dewhirst,
S. L. W. On,
A. Porter,
R. J. Owen, and M. Costas.
1994.
Helicobacter pullorum sp. nov. genotype and phenotype of a new species isolated from poultry and from human patients with gastroenteritis.
Microbiology
140:3441-3449[Abstract].
|
| 42. | Studier, J. A., and K. J. Keppler. 1988. A note on the neighbor-joining algorithm of Saitou and Nei. Mol. Biol. Evol. 5:729-731[Medline]. |
| 43. | Swofford, D. L., and G. J. Olsen. 1990. Phylogeny reconstruction, p. 411-501. In D. M. Hillis, and C. Moritz (ed.), Molecular systematics. Sinauer Association, Inc., Sunderland, Mass. |
| 44. |
Vandamme, P.,
E. Falsen,
B. Pot,
K. Kersters, and J. De Ley.
1990.
Identification of Campylobacter cinaedi isolated from blood and feces of children and adult females.
J. Clin. Microbiol.
28:1016-1020 |
| 45. | Ward, J. M., M. R. Anver, D. C. Haines, and R. E. Benveniste. 1994. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am. J. Pathol. 145:959-968[Abstract]. |
| 46. | Ward, J. M., M. R. Anver, D. C. Haines, J. M. Melhorn, P. Gorelick, L. Yan, and J. G. Fox. 1996. Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab. Anim. Sci. 46:15-20[Medline]. |
| 47. |
Ward, J. M.,
J. G. Fox,
M. R. Anver,
D. C. Haines,
C. V. George,
M. J. Collins, Jr.,
P. L. Gorelick,
K. Nagashima,
M. A. Gonda,
R. V. Gilden, et al.
1994.
Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.
J. Natl. Cancer Inst.
86:1222-1227 |
| 48. |
Witherell, H. L.,
S. Hansen,
E. Jellum,
N. Orentreich,
J. H. Vogelman, and J. Parsonnet.
1997.
Risk for gastric lymphoma in persons with CagA+ and CagA Helicobacter pylori infection.
J. Infect. Dis.
176:1641-1644[Medline].
|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|